Among all PCa, around 5–10% are PSMA-negative on immunohistochemical PSMA expression, and, of those, about 10% give a negative PSMA-PET result, in spite of a rising PSA level [25]. This evidence concerns the gene KLK3 and posterior cortical atrophy.